Secondary Myelofibrosis Market Outlook: Epidemiology and Growth Forecast to 2032
Secondary Myelofibrosis - Market Insight, Epidemiology, and Market Forecast – 2032
Secondary Myelofibrosis (SMF) is a rare and chronic bone marrow disorder that develops as a progression from other myeloproliferative neoplasms (MPNs), such as polycythemia vera or essential thrombocythemia. It is characterized by the replacement of bone marrow with fibrous tissue, leading to anemia,...